Blueshift Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Blueshift Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,419	Closed	-$308K	–	1275
2021 Q1	$308K	Buy	+1,419	New	+$267K	0.03%	628
2019 Q3	–	Sell	-1,983	Closed	-$342K	–	1031
2019 Q2	$342K	Buy	+1,983	New	+$343K	0.04%	500

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Blueshift Asset Management's GWPH Position: Q2 2021 in Review

Blueshift Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,419 shares — an estimated $308K sold.

Blueshift Asset Management first reported a position in GWPH in Q2 2019 and held it in 2 quarters. The position peaked at $342K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Blueshift Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Blueshift Asset Management sold 1,419 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $308K.
Blueshift Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
Blueshift Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $342K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.